Pantelis Pavlos, Theocharous Giorgos, Veroutis Dimitris, Vagena Ioanna-Aglaia, Polyzou Aikaterini, Thanos Dimitris-Foivos, Kyrodimos Efthymios, Kotsinas Athanassios, Evangelou Konstantinos, Lagopati Nefeli, Gorgoulis Vassilis G, Kotopoulos Nicholas
Molecular Carcinogenesis Group, Department of Histology and Embryology, Medical School, National and Kapodistrian University of Athens (NKUA), 11527 Athens, Greece.
Laboratory of Biology, Department of Basic Medical Sciences, Medical School, National and Kapodistrian University of Athens (NKUA), 11527 Athens, Greece.
Int J Mol Sci. 2024 Feb 20;25(5):2473. doi: 10.3390/ijms25052473.
The currently available anti-cancer therapies, such as gamma-radiation and chemotherapeutic agents, induce cell death and cellular senescence not only in cancer cells but also in the adjacent normal tissue. New anti-tumor approaches focus on limiting the side effects on normal cells. In this frame, the potential anti-tumor properties of Pulsed Electromagnetic Fields (PEMFs) through the irradiation of breast cancer epithelial cells (MCF-7 and MDA-MB-231) and normal fibroblasts (FF95) were investigated. PEMFs had a frequency of 8 Hz, full-square wave type and magnetic flux density of 0.011 T and were applied twice daily for 5 days. The data collected showcase that PEMF application decreases the proliferation rate and viability of breast cancer cells while having the opposite effect on normal fibroblasts. Moreover, PEMF irradiation induces cell death and cellular senescence only in breast cancer cells without any effect in the non-cancerous cells. These findings suggest PEMF irradiation as a novel, non-invasive anti-cancer strategy that, when combined with senolytic drugs, may eliminate both cancer and the remaining senescent cells, while simultaneously avoiding the side effects of the current treatments.
Int J Mol Sci. 2024-2-20
Technol Cancer Res Treat. 2022
Cell Mol Life Sci. 2025-8-31
Oncol Lett. 2025-4-25
Zhongguo Fei Ai Za Zhi. 2024-12-20
Pharmaceutics. 2022-12-30
Clin Med (Lond). 2022-5
Cancer Discov. 2022-1
Int J Mol Sci. 2021-7-9